Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating expenses:
General and administrative	$ 468	$ 303
Research and development	598	350
Operating loss	(1,066)	(653)
Other (expense) income:
Interest expense	(4)	(1,033)
Other(expense) income	(820)	34
Total other expense	(824)	(999)
Loss before income tax benefit	(1,890)	(1,652)
Income tax benefit	92	71
Net loss	(1,798)	(1,581)
Foreign currency translation adjustment	797	(32)
Comprehensive loss	$ (1,001)	$ (1,613)
Basic and diluted net loss per share (in dollars per share)	$ (0.27)	$ (0.31)
Weighted average shares outstanding - basic and diluted (in shares)	6,631,308	5,072,397